Literature DB >> 25813158

Small cyclic agonists of iron regulatory hormone hepcidin.

Kristine Chua1, Eileen Fung1, Ewa D Micewicz2, Tomas Ganz1, Elizabeta Nemeth1, Piotr Ruchala3.   

Abstract

Minihepcidins are in vitro and in vivo active mimetics of iron-regulatory hormone hepcidin. They contain various unusual amino acids including: N-substituted, β-homo-, and d-amino acids with their combination depending on particular minihepcidin. In the current study, we sought to limit the use of unusual/more expensive amino acids derivatives by peptide cyclization. Novel cyclic mimetics of hepcidin were synthesized and tested in vitro and showed activity at low nanomolar concentration. Nonetheless, the most active cyclic compound (mHS17) is approximately ten times less active than the parental minihepcidin PR73. Collectively, our findings suggest that cyclization is viable approach in the synthesis of hepcidin mimetics.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cyclization; Iron; Minihepcidins; Peptides; S-alkylation of peptides

Mesh:

Substances:

Year:  2015        PMID: 25813158      PMCID: PMC4567957          DOI: 10.1016/j.bmcl.2015.03.012

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  50 in total

Review 1.  "Green" atom transfer radical polymerization: from process design to preparation of well-defined environmentally friendly polymeric materials.

Authors:  Nicolay V Tsarevsky; Krzysztof Matyjaszewski
Journal:  Chem Rev       Date:  2007-05-27       Impact factor: 60.622

Review 2.  Polycyclic peptide therapeutics.

Authors:  Vanessa Baeriswyl; Christian Heinis
Journal:  ChemMedChem       Date:  2013-01-25       Impact factor: 3.466

3.  Dithiol amino acids can structurally shape and enhance the ligand-binding properties of polypeptides.

Authors:  Shiyu Chen; Ranganath Gopalakrishnan; Tifany Schaer; Fabrice Marger; Ruud Hovius; Daniel Bertrand; Florence Pojer; Christian Heinis
Journal:  Nat Chem       Date:  2014-08-31       Impact factor: 24.427

4.  Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis.

Authors:  Emilio Ramos; Piotr Ruchala; Julia B Goodnough; Léon Kautz; Gloria C Preza; Elizabeta Nemeth; Tomas Ganz
Journal:  Blood       Date:  2012-09-18       Impact factor: 22.113

5.  Understanding the structure/activity relationships of the iron regulatory peptide hepcidin.

Authors:  Richard J Clark; Chia Chia Tan; Gloria C Preza; Elizabeta Nemeth; Tomas Ganz; David J Craik
Journal:  Chem Biol       Date:  2011-03-25

6.  Peptide lipidation stabilizes structure to enhance biological function.

Authors:  Brian P Ward; Nickki L Ottaway; Diego Perez-Tilve; Dejian Ma; Vasily M Gelfanov; Matthias H Tschöp; Richard D Dimarchi
Journal:  Mol Metab       Date:  2013-09-05       Impact factor: 7.422

7.  Improvement of HIV fusion inhibitor C34 efficacy by membrane anchoring and enhanced exposure.

Authors:  Marcelo T Augusto; Axel Hollmann; Miguel A R B Castanho; Matteo Porotto; Antonello Pessi; Nuno C Santos
Journal:  J Antimicrob Chemother       Date:  2014-01-23       Impact factor: 5.790

Review 8.  Manipulation of the hepcidin pathway for therapeutic purposes.

Authors:  Eileen Fung; Elizabeta Nemeth
Journal:  Haematologica       Date:  2013-11       Impact factor: 9.941

9.  On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds.

Authors:  Tina R White; Chad M Renzelman; Arthur C Rand; Taha Rezai; Cayla M McEwen; Vladimir M Gelev; Rushia A Turner; Roger G Linington; Siegfried S F Leung; Amit S Kalgutkar; Jonathan N Bauman; Yizhong Zhang; Spiros Liras; David A Price; Alan M Mathiowetz; Matthew P Jacobson; R Scott Lokey
Journal:  Nat Chem Biol       Date:  2011-09-25       Impact factor: 15.040

Review 10.  Hepcidin antagonists for potential treatments of disorders with hepcidin excess.

Authors:  Maura Poli; Michela Asperti; Paola Ruzzenenti; Maria Regoni; Paolo Arosio
Journal:  Front Pharmacol       Date:  2014-04-28       Impact factor: 5.810

View more
  13 in total

1.  The C19S Substitution Enhances the Stability of Hepcidin While Conserving Its Biological Activity.

Authors:  Edina Pandur; Zsuzsanna Fekete; Kitti Tamási; László Grama; Edit Varga; Katalin Sipos
Journal:  Protein J       Date:  2018-04       Impact factor: 2.371

2.  Position of lipidation influences anticancer activity of Smac analogs.

Authors:  Ewa D Micewicz; Christine Nguyen; Alina Micewicz; Alan J Waring; William H McBride; Piotr Ruchala
Journal:  Bioorg Med Chem Lett       Date:  2019-04-26       Impact factor: 2.823

3.  Lipid-conjugated Smac analogues.

Authors:  Ewa D Micewicz; Josephine A Ratikan; Alan J Waring; Julian P Whitelegge; William H McBride; Piotr Ruchala
Journal:  Bioorg Med Chem Lett       Date:  2015-09-08       Impact factor: 2.823

4.  Fluorescence resonance energy transfer links membrane ferroportin, hephaestin but not ferroportin, amyloid precursor protein complex with iron efflux.

Authors:  Adrienne C Dlouhy; Danielle K Bailey; Brittany L Steimle; Haley V Parker; Daniel J Kosman
Journal:  J Biol Chem       Date:  2019-01-15       Impact factor: 5.157

5.  Bridged Analogues for p53-Dependent Cancer Therapy Obtained by S-Alkylation.

Authors:  Ewa D Micewicz; Shantanu Sharma; Alan J Waring; Hai T Luong; William H McBride; Piotr Ruchala
Journal:  Int J Pept Res Ther       Date:  2015-08-19       Impact factor: 1.931

Review 6.  Retinal abnormalities in β-thalassemia major.

Authors:  Devang L Bhoiwala; Joshua L Dunaief
Journal:  Surv Ophthalmol       Date:  2015-08-29       Impact factor: 6.048

Review 7.  Current understanding of iron homeostasis.

Authors:  Gregory J Anderson; David M Frazer
Journal:  Am J Clin Nutr       Date:  2017-10-25       Impact factor: 7.045

Review 8.  Hepcidin: A Promising Therapeutic Target for Iron Disorders: A Systematic Review.

Authors:  Jing Liu; Bingbing Sun; Huijun Yin; Sijin Liu
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

9.  Hepcidin and Iron Homeostasis in Patients with Subacute Thyroiditis and Healthy Subjects.

Authors:  Aleksandra Hernik; Ewelina Szczepanek-Parulska; Dorota Filipowicz; Agata Czarnywojtek; Elżbieta Wrotkowska; Lucyna Kramer; Alina Urbanovych; Marek Ruchała
Journal:  Mediators Inflamm       Date:  2019-02-27       Impact factor: 4.711

Review 10.  Pharmacological Targeting of the Hepcidin/Ferroportin Axis.

Authors:  Giada Sebastiani; Nicole Wilkinson; Kostas Pantopoulos
Journal:  Front Pharmacol       Date:  2016-06-21       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.